CMR Surgical announces that Supratim Bose has become Chief Executive Officer, taking over from Per Vegard Nerseth with immediate effect.
Supratim joined the Company in February 2023 as a senior advisor to the CEO, taking over the leadership of the Asia, Middle East and Africa region, leading commercial operations across the three regions.
Supratim joins CMR with more than 40 years of extensive senior leadership experience in the medical technology industry. He has held several leadership positions in global organisations, including Johnson & Johnson (J&J), Boston Scientific and ConvaTec. Supratim takes up the appointment as the Company further commercialises the business, with more than 100 Versius systems installed globally.
With extensive MedTech leadership experience, Supratim will now step into the role of CEO, overseeing the Company’s global roll out of the Versius® Surgical Robotic System.
Umur Hursever, on behalf of the Board of CMR Surgical, commented: “We are delighted to have someone of Supratim’s experience leading CMR. CMR has a very powerful mission to bring minimal access surgery to everyone who needs it, and given Supratim’s exceptional track record leading global MedTech businesses I am excited to work with him and the leadership team to continue to disrupt the market. I would like to thank Per Vegard for his contributions to CMR and wish him well for the future.”
Supratim Bose, Chief Executive Officer of CMR Surgical, said: “With Versius we have an opportunity to help hospitals and surgeons transform surgery for people around the world. I am excited to lead a business that has such a differentiated product with Versius, that is addressing a high unmet need for better surgical care around the world. I look forward to working with everyone at CMR to bring the benefits of surgical robotics to hospitals and surgeons around the world.”
Per Vegard Nerseth said: “During my time at the Company I am proud to have seen CMR expand its commercial operations and bring Versius into the hands of more surgeons and hospitals. After experiencing strong growth, CMR is now the second largest surgical robotics company on the market with a significant presence across four continents. I look forward to seeing the Company continue to grow so that more hospitals and patients can benefit from minimal access surgery.”
CMR now has operations in more than 20 markets with growing demand for a versatile surgical robotic system. Versius is the only small, versatile, modular and portable surgical robot on the market and is suitable for all sizes of hospitals and surgical care centres. The system allows surgeons the versatility to perform fully robotic as well as a combination of robotic and manual laparoscopic procedures, giving them freedom to decide how to provide patients with the best possible surgical care.
Source: CMR Surgical